Forecast: Polio Vaccine Third Dose (Pol3) Immunization Coverage in Argentina

Polio Vaccine Third Dose (Pol3) Immunization Coverage in Argentina demonstrated a gradual decline from 2015 onwards. After peaking at 93% in 2015, coverage consistently dropped, reaching 82% in 2023. This is a significant observation as the year-on-year variation often saw declines, with -1.2% in 2022 and remaining stagnant in 2023. Over the last five years, from 2019 to 2023, the average annual decline (CAGR) stood at -0.48%. Future forecasts predict this downward trend will continue, reaching 79% by 2028, forecasting an average annual decline of -0.5% and a total five-year reduction of -2.47%.

Future trends to watch for include potential shifts due to public health policy changes, vaccine distribution efficiency, public awareness initiatives, and potential socio-economic factors that may influence immunization coverage levels. Monitoring these elements can help in formulating strategies to stabilize or improve coverage rates.

Latest reports

 US Vaccine Market Report- Q1 2025

US Vaccine Market Report- Q1 2025

The US vaccine market in the first quarter of 2025 is characterized by significant growth and innovation, driven by technological advancements, strategic government...

 China Vaccine Market Report- Q1 2025

China Vaccine Market Report- Q1 2025

The first quarter of 2025 marked a period of dynamic change and growth for the vaccine market in China, driven by strategic government...

 Japan Vaccine Market Report- Q4 2024

Japan Vaccine Market Report- Q4 2024

In the fourth quarter of 2024, Japan's vaccine market saw significant developments across various segments, with a focus on technological innovation and strategic...

 Germany Vaccine Market Report- Q4 2024

Germany Vaccine Market Report- Q4 2024

In the fourth quarter of 2024, the vaccine market in Germany experienced significant transformations driven by technological advancements and strategic collaborations. The focus...

 India Vaccine Market Report- Q4 2024

India Vaccine Market Report- Q4 2024

The vaccine market in India witnessed significant developments in Q4 2024, driven by strategic initiatives and governmental policies aimed at bolstering production and...

 UK Vaccine Market Report- Q4 2024

UK Vaccine Market Report- Q4 2024

The UK vaccine market in Q4 2024 experienced notable developments driven by legal, economic, and strategic factors. The quarter was marked by significant...

 France Vaccine Market Report- Q4 2024

France Vaccine Market Report- Q4 2024

The fourth quarter of 2024 marked a transformative period for the vaccine market in France, characterized by significant strategic developments, technological advancements, and...

 Canada Vaccine Market Report- Q4 2024

Canada Vaccine Market Report- Q4 2024

The Canadian vaccine market in the fourth quarter of 2024 is characterized by strategic partnerships, significant investment trends, the emergence of novel vaccine...

 Brazil Vaccine Market Report- Q4 2024

Brazil Vaccine Market Report- Q4 2024

The fourth quarter of 2024 witnessed significant developments in the Brazilian vaccine market, underscored by a combination of technological advancements, strategic partnerships, and...

 Italy Vaccine Market Report- Q4 2024

Italy Vaccine Market Report- Q4 2024

The fourth quarter of 2024 marked significant developments in the vaccine market in Italy, with a notable focus on vaccine production, distribution, and...

Top Countries about mRNA Vaccine